{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:04:57Z","timestamp":1788998697131,"version":"build-2803163510"},"reference-count":178,"publisher":"Elsevier","isbn-type":[{"value":"9780443186691","type":"print"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/bs.pmbts.2023.01.002","type":"book-chapter","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T22:30:54Z","timestamp":1675809054000},"page":"105-134","source":"Crossref","is-referenced-by-count":9,"title":["Epigenetics in cardiovascular health and disease"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.pmbts.2023.01.002_bb0010","series-title":"The strategy of the genes. A discussion of some aspects of theoretical biology. With an appendix by H. Kacser","author":"Waddington","year":"1957"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0015","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrd.2016.245","article-title":"Induced pluripotent stem cell technology: a decade of progress","volume":"16","author":"Shi","year":"2017","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0025","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1073\/pnas.0910012107","article-title":"Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency","volume":"107","author":"Hu","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0030","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a018200","article-title":"A brief history of epigenetics","volume":"6","author":"Felsenfeld","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000130315","article-title":"X inactivation, differentiation, and DNA methylation","volume":"14","author":"Riggs","year":"1975","journal-title":"Cytogenet Cell Genet"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0040","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0045","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2012.10.001","article-title":"SnapShot: small RNA-mediated epigenetic modifications","volume":"151","author":"Zaratiegui","year":"2012","journal-title":"Cell"},{"issue":"19","key":"10.1016\/bs.pmbts.2023.01.002_bb0050","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1161\/CIRCULATIONAHA.110.956839","article-title":"Epigenetic modifications: basic mechanisms and role in cardiovascular disease","volume":"123","author":"Handy","year":"2011","journal-title":"Circulation"},{"issue":"25","key":"10.1016\/bs.pmbts.2023.01.002_bb0055","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"9921","key":"10.1016\/bs.pmbts.2023.01.002_bb0060","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","article-title":"The Framingham heart study and the epidemiology of cardiovascular disease: a historical perspective","volume":"383","author":"Mahmood","year":"2014","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0065","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10654-007-9199-x","article-title":"The Rotterdam study: objectives and design update","volume":"22","author":"Hofman","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/978-3-319-43624-1_10","article-title":"N6-Methyladenine: a conserved and dynamic DNA mark","volume":"945","author":"O'Brown","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0075","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/nar\/gkz1082","article-title":"Epigenetic modification of cytosines fine tunes the stability of i-motif DNA","volume":"48","author":"Wright","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","article-title":"The diverse roles of DNA methylation in mammalian development and disease","volume":"20","author":"Greenberg","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-4419-9967-2_1","article-title":"DNA methyltransferases, DNA damage repair, and cancer","volume":"754","author":"Jin","year":"2013","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0090","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/890","article-title":"Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases","volume":"19","author":"Okano","year":"1998","journal-title":"Nat Genet"},{"issue":"4173","key":"10.1016\/bs.pmbts.2023.01.002_bb0095","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1126\/science.187.4173.226","article-title":"DNA modification mechanisms and gene activity during development","volume":"187","author":"Holliday","year":"1975","journal-title":"Science"},{"issue":"20","key":"10.1016\/bs.pmbts.2023.01.002_bb0100","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1093\/nar\/8.20.4763","article-title":"Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA","volume":"8","author":"Kuo","year":"1980","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13059-018-1408-2","article-title":"Comparison of whole-genome bisulfite sequencing library preparation strategies identifies sources of biases affecting DNA methylation data","volume":"19","author":"Olova","year":"2018","journal-title":"Genome Biol"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0110","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.bpj.2011.07.057","article-title":"Dissecting DNA-histone interactions in the nucleosome by molecular dynamics simulations of DNA unwrapping","volume":"101","author":"Ettig","year":"2011","journal-title":"Biophys J"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0115","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-60327-414-2_1","article-title":"The state-of-the-art of chromatin immunoprecipitation","volume":"567","author":"Collas","year":"2009","journal-title":"Methods Mol Biol"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0125","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrg2641","article-title":"ChIP-seq: advantages and challenges of a maturing technology","volume":"10","author":"Park","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.01.002_bb0130","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nmeth.2688","article-title":"Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position","volume":"10","author":"Buenrostro","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0135","doi-asserted-by":"crossref","DOI":"10.1002\/0471142727.mb2129s109","article-title":"ATAC-seq: a method for assaying chromatin accessibility genome-wide","volume":"109","author":"Buenrostro","year":"2015","journal-title":"Curr Protoc Mol Biol"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.01.002_bb0140","doi-asserted-by":"crossref","first-page":"R119","DOI":"10.1186\/gb-2010-11-12-r119","article-title":"Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition","volume":"11","author":"Adey","year":"2010","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0145","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13059-020-1929-3","article-title":"From reads to insight: a hitchhiker's guide to ATAC-seq data analysis","volume":"21","author":"Yan","year":"2020","journal-title":"Genome Biol"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0150","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.cell.2018.06.052","article-title":"A single-cell atlas of in vivo mammalian chromatin accessibility","volume":"174","author":"Cusanovich","year":"2018","journal-title":"Cell"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0155","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ng.3646","article-title":"Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution","volume":"48","author":"Corces","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0160","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1016\/j.molcel.2022.03.009","article-title":"Single-cell profiling of transcriptome and histone modifications with EpiDamID","volume":"82","author":"Rang","year":"2022","journal-title":"Mol Cell"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.01.002_bb0165","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0170","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1161\/CIRCRESAHA.117.311802","article-title":"Long noncoding RNA discovery in cardiovascular disease: decoding form to function","volume":"122","author":"Sallam","year":"2018","journal-title":"Circ Res"},{"issue":"7235","key":"10.1016\/bs.pmbts.2023.01.002_bb0175","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nature07672","article-title":"Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals","volume":"458","author":"Guttman","year":"2009","journal-title":"Nature"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","article-title":"Regulation of microRNA function in animals","volume":"20","author":"Gebert","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0185","first-page":"60","article-title":"MicroRNA and cardiovascular diseases","volume":"37","author":"\u00c7akmak","year":"2020","journal-title":"Balkan Med J"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0190","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.118.11126","article-title":"Noncoding RNAs in the regulatory network of hypertension","volume":"72","author":"Wu","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0195","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/bib\/bby055","article-title":"The small peptide world in long noncoding RNAs","volume":"20","author":"Choi","year":"2019","journal-title":"Brief Bioinform"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.002_bb0200","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrcardio.2015.55","article-title":"Long noncoding RNAs in cardiac development and ageing","volume":"12","author":"Devaux","year":"2015","journal-title":"Nat Rev Cardiol"},{"issue":"7455","key":"10.1016\/bs.pmbts.2023.01.002_bb0205","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/nature12210","article-title":"Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation","volume":"498","author":"Li","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0210","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.devcel.2012.12.012","article-title":"The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse","volume":"24","author":"Grote","year":"2013","journal-title":"Dev Cell"},{"issue":"7441","key":"10.1016\/bs.pmbts.2023.01.002_bb0215","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature11928","article-title":"Circular RNAs are a large class of animal RNAs with regulatory potency","volume":"495","author":"Memczak","year":"2013","journal-title":"Nature"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0220","first-page":"298","article-title":"A landscape of circular RNA expression in the human heart","volume":"113","author":"Tan","year":"2017","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0225","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrg2484","article-title":"RNA-Seq: a revolutionary tool for transcriptomics","volume":"10","author":"Wang","year":"2009","journal-title":"Nat Rev Genet"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0230","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1101\/pdb.top084970","article-title":"RNA sequencing and analysis","volume":"2015","author":"Kukurba","year":"2015","journal-title":"Cold Spring Harb Protoc"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.002_bb0235","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nbt.1883","article-title":"Full-length transcriptome assembly from RNA-Seq data without a reference genome","volume":"29","author":"Grabherr","year":"2011","journal-title":"Nat Biotechnol"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0240","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ng.384","article-title":"Genome-wide association study of blood pressure and hypertension","volume":"41","author":"Levy","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0245","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0250","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1161\/HYPERTENSIONAHA.111.190116","article-title":"Report of the National Heart, Lung, and Blood Institute working group on epigenetics and hypertension","volume":"59","author":"Cowley","year":"2012","journal-title":"Hypertension"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0255","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1038\/hr.2011.105","article-title":"The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin-angiotensin-aldosterone system, oxidative stress and endogenous digitalis in the brain","volume":"34","author":"Takahashi","year":"2011","journal-title":"Hypertens Res"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0260","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/HYPERTENSIONAHA.118.11171","article-title":"Epigenetic mechanisms and hypertension","volume":"72","author":"Liang","year":"2018","journal-title":"Hypertension"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0265","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1172\/JCI21647","article-title":"Epigenetic regulation of 11 beta-hydroxysteroid dehydrogenase type 2 expression","volume":"114","author":"Alikhani-Koopaei","year":"2004","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0270","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41371-019-0218-7","article-title":"The role of DNA methylation and histone modifications in blood pressure: a systematic review","volume":"33","author":"Gonzalez-Jaramillo","year":"2019","journal-title":"J Hum Hypertens"},{"issue":"26","key":"10.1016\/bs.pmbts.2023.01.002_bb0275","doi-asserted-by":"crossref","first-page":"24824","DOI":"10.1074\/jbc.M502115200","article-title":"The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code","volume":"280","author":"Fish","year":"2005","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0280","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/HYPERTENSIONAHA.111.182428","article-title":"Tissue-specific upregulation of angiotensin-converting enzyme 1 in spontaneously hypertensive rats through histone code modifications","volume":"59","author":"Lee","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0285","doi-asserted-by":"crossref","first-page":"H699","DOI":"10.1152\/ajpheart.01152.2007","article-title":"Identity of the renin cell is mediated by cAMP and chromatin remodeling: an in vitro model for studying cell recruitment and plasticity","volume":"294","author":"Pentz","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0290","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/hr.2012.37","article-title":"Upregulation of the Na(+)-K(+)-2Cl(\u2212) cotransporter 1 via histone modification in the aortas of angiotensin II-induced hypertensive rats","volume":"35","author":"Cho","year":"2012","journal-title":"Hypertens Res"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0295","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19040927","article-title":"Non-coding RNA in the pathogenesis, progression and treatment of hypertension","volume":"19","author":"Leimena","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"17","key":"10.1016\/bs.pmbts.2023.01.002_bb0300","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006417","article-title":"micro-RNA screening and prediction model construction for diagnosis of salt-sensitive essential hypertension","volume":"96","author":"Qi","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0305","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.111.180729","article-title":"Gene expression profiling reveals renin mRNA overexpression in human hypertensive kidneys and a role for microRNAs","volume":"58","author":"Marques","year":"2011","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.002_bb0310","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/s41440-020-0408-2","article-title":"Long noncoding RNAs as novel players in the pathogenesis of hypertension","volume":"43","author":"Jiang","year":"2020","journal-title":"Hypertens Res"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0315","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/HYPERTENSIONAHA.117.09651","article-title":"AK098656, a novel vascular smooth muscle cell-dominant long noncoding RNA, promotes hypertension","volume":"71","author":"Jin","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112095","article-title":"Factors regulating dynamics of angiotensin-converting enzyme-2 (ACE2), the gateway of SARS-CoV-2: Epigenetic modifications and therapeutic interventions by epidrugs","volume":"143","author":"Rath","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0325","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.numecd.2014.01.016","article-title":"The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials","volume":"24","author":"Onakpoya","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0330","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.117.309732","article-title":"Atrial fibrillation: epidemiology, pathophysiology, and clinical outcomes","volume":"120","author":"Staerk","year":"2017","journal-title":"Circ Res"},{"issue":"22","key":"10.1016\/bs.pmbts.2023.01.002_bb0335","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.jacc.2014.02.555","article-title":"Atrial remodeling and atrial fibrillation: recent advances and translational perspectives","volume":"63","author":"Nattel","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/bs.pmbts.2023.01.002_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165717","article-title":"Genetics and epigenetics of atrial fibrillation","volume":"21","author":"Lozano-Velasco","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0345","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/clc.22715","article-title":"DNA methylation dysregulations in valvular atrial fibrillation","volume":"40","author":"Shen","year":"2017","journal-title":"Clin Cardiol"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0350","doi-asserted-by":"crossref","first-page":"40377","DOI":"10.1038\/srep40377","article-title":"Methylome-wide association study of atrial fibrillation in Framingham heart study","volume":"7","author":"Lin","year":"2017","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0355","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.tcm.2015.08.006","article-title":"Epigenetic mechanisms in atrial fibrillation: new insights and future directions","volume":"26","author":"Tao","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0360","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tox.2014.06.006","article-title":"DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1\/2","volume":"323","author":"Tao","year":"2014","journal-title":"Toxicology"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0365","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/ng.1009","article-title":"Dnmt3a is essential for hematopoietic stem cell differentiation","volume":"44","author":"Challen","year":"2011","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0370","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1161\/CIRCULATIONAHA.113.005300","article-title":"Activation of histone deacetylase-6 induces contractile dysfunction through derailment of \u03b1-tubulin proteostasis in experimental and human atrial fibrillation","volume":"129","author":"Zhang","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0375","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.yjmcc.2008.08.015","article-title":"Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin","volume":"45","author":"Liu","year":"2008","journal-title":"J Mol Cell Cardiol"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0380","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/cvr\/cvv265","article-title":"Keeping up the balance: role of HDACs in cardiac proteostasis and therapeutic implications for atrial fibrillation","volume":"109","author":"Zhang","year":"2016","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0385","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/jpet.116.234591","article-title":"Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation","volume":"358","author":"Seki","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"6868","key":"10.1016\/bs.pmbts.2023.01.002_bb0390","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50 years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.01.002_bb0395","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/j.hrthm.2009.08.035","article-title":"Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation","volume":"6","author":"Girmatsion","year":"2009","journal-title":"Heart Rhythm"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0400","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1172\/JCI62185","article-title":"MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation","volume":"123","author":"Luo","year":"2013","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.002_bb0405","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.hrthm.2013.03.005","article-title":"Regulation of the SK3 channel by microRNA-499\u2014potential role in atrial fibrillation","volume":"10","author":"Ling","year":"2013","journal-title":"Heart Rhythm"},{"issue":"10 Pt A","key":"10.1016\/bs.pmbts.2023.01.002_bb0410","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.bbadis.2015.07.016","article-title":"Post-transcriptional regulation of cardiac sodium channel gene SCN5A expression and function by miR-192-5p","volume":"1852","author":"Zhao","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.002_bb0415","first-page":"8402","article-title":"Long non-coding RNA expression profile in atrial fibrillation","volume":"8","author":"Ruan","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"issue":"7","key":"10.1016\/bs.pmbts.2023.01.002_bb0420","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.hlc.2019.10.018","article-title":"Identification of long non-coding RNA and circular RNA expression profiles in atrial fibrillation","volume":"29","author":"Wu","year":"2020","journal-title":"Heart Lung Circ"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2017.05.009","article-title":"Altered long non-coding RNA expression profile in rabbit atria with atrial fibrillation: TCONS_00075467 modulates atrial electrical remodeling by sponging miR-328 to regulate CACNA1C","volume":"108","author":"Li","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0430","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.597932","article-title":"Expression profiles of circular RNA in human atrial fibrillation with Valvular heart diseases","volume":"7","author":"Zhu","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0435","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.7150\/thno.71813","article-title":"The mechanistic pathways of oxidative stress in aortic stenosis and clinical implications","volume":"12","author":"Phua","year":"2022","journal-title":"Theranostics"},{"issue":"35","key":"10.1016\/bs.pmbts.2023.01.002_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202202169","article-title":"Reactive oxygen species scavenging nanomedicine for the treatment of ischemic heart disease","volume":"34","author":"Zhang","year":"2022","journal-title":"Adv Mater"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0445","first-page":"927","article-title":"Atherosclerosis: process, indicators, risk factors and new hopes","volume":"5","author":"Rafieian-Kopaei","year":"2014","journal-title":"Int J Prev Med"},{"issue":"6a","key":"10.1016\/bs.pmbts.2023.01.002_bb0450","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1582-4934.2010.01022.x","article-title":"Epigenetics in atherosclerosis and inflammation","volume":"14","author":"Wierda","year":"2010","journal-title":"J Cell Mol Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0455","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0460","article-title":"Recognition of oxidized lipids by macrophages and its role in atherosclerosis development","volume":"9","author":"Mushenkova","year":"2021","journal-title":"Biomedicine"},{"issue":"13","key":"10.1016\/bs.pmbts.2023.01.002_bb0465","first-page":"2525","article-title":"Inflammation during the life cycle of the atherosclerotic plaque","volume":"117","author":"Libby","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0470","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1161\/ATVBAHA.119.312578","article-title":"Myocardial infarction-from atherosclerosis to thrombosis","volume":"39","author":"Palasubramaniam","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0475","article-title":"Meta-analysis of the placebo and nocebo effects associated with placebo treatment in randomized trials of lipid lowering therapy","author":"Chin","year":"2022","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0480","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.810689","article-title":"Epigenetic regulation in pathology of atherosclerosis: a novel perspective","volume":"12","author":"Tang","year":"2021","journal-title":"Front Genet"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0485","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCGENETICS.113.000441","article-title":"DNA methylation map of human atherosclerosis","volume":"7","author":"Zaina","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0490","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12920-015-0085-1","article-title":"The DNA methylation drift of the atherosclerotic aorta increases with lesion progression","volume":"8","author":"Valencia-Morales Mdel","year":"2015","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0495","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12920-022-01259-z","article-title":"Integrated investigation of DNA methylation, gene expression and immune cell population revealed immune cell infiltration associated with atherosclerotic plaque formation","volume":"15","author":"Yin","year":"2022","journal-title":"BMC Med Genomics"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0500","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1093\/eurheartj\/ehn603","article-title":"Epigenetic histone acetylation modifiers in vascular remodelling: new targets for therapy in cardiovascular disease","volume":"30","author":"Pons","year":"2009","journal-title":"Eur Heart J"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0505","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.15252\/emmm.201404170","article-title":"Targeting macrophage histone deacetylase 3 stabilizes atherosclerotic lesions","volume":"6","author":"Hoeksema","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0510","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid type I interferon signaling promotes atherosclerosis by stimulating macrophage recruitment to lesions","volume":"12","author":"Goossens","year":"2010","journal-title":"Cell Metab"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0515","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13148-020-00826-4","article-title":"Histone methylation and vascular biology","volume":"12","author":"Wei","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0520","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1089\/ars.2020.8107","article-title":"MicroRNAs as master regulators of atherosclerosis: from pathogenesis to novel therapeutic options","volume":"33","author":"Hosen","year":"2020","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0525","first-page":"313","article-title":"MicroRNAs in the pathobiology and therapy of atherosclerosis","volume":"33","author":"Laffont","year":"2017","journal-title":"Can J Cardiol"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0530","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1161\/ATVBAHA.120.314222","article-title":"Long noncoding RNAs in atherosclerosis and vascular injury: pathobiology, biomarkers, and targets for therapy","volume":"40","author":"Pierce","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0535","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170351","article-title":"Thymic stromal lymphopoietin-induced HOTAIR activation promotes endothelial cell proliferation and migration in atherosclerosis","volume":"37","author":"Peng","year":"2017","journal-title":"Biosci Rep"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117837","article-title":"Circular RNAs in the pathogenesis of atherosclerosis","volume":"255","author":"Cao","year":"2020","journal-title":"Life Sci"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.971484","article-title":"The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases","volume":"13","author":"Chew","year":"2022","journal-title":"Front Genet"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0550","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/ehf2.13822","article-title":"Can glucose-lowering medications improve outcomes in non-diabetic heart failure patients? A Bayesian network meta-analysis","volume":"9","author":"Yeong","year":"2022","journal-title":"ESC Heart Fail"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0555","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/HCO.0000000000000160","article-title":"Genetics of common forms of heart failure: challenges and potential solutions","volume":"30","author":"Rau","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0560","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/CIRCHEARTFAILURE.114.001193","article-title":"Epigenetic mechanisms in heart failure pathogenesis","volume":"7","author":"Di Salvo","year":"2014","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008564","article-title":"Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure","volume":"5","author":"Movassagh","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0570","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005765","article-title":"Targeted DNA methylation profiling of human cardiac tissue reveals novel epigenetic traits and gene deregulation across different heart failure patient subtypes","volume":"12","author":"Glezeva","year":"2019","journal-title":"Circ Heart Fail"},{"issue":"50","key":"10.1016\/bs.pmbts.2023.01.002_bb0575","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1073\/pnas.1315155110","article-title":"Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy","volume":"110","author":"Papait","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0580","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41467-017-02762-z","article-title":"Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo","volume":"9","author":"Gilsbach","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0585","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2443.2008.01252.x","article-title":"Genome-wide histone methylation profile for heart failure","volume":"14","author":"Kaneda","year":"2009","journal-title":"Genes Cells"},{"issue":"17","key":"10.1016\/bs.pmbts.2023.01.002_bb0590","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00018-018-2857-1","article-title":"Histones and heart failure in diabetes","volume":"75","author":"Yerra","year":"2018","journal-title":"Cell Mol Life Sci"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0595","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.jacbts.2019.05.011","article-title":"Epigenetics in cardiac hypertrophy and heart failure","volume":"4","author":"Liu","year":"2019","journal-title":"JACC Basic Transl Sci"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0600","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.119.042474","article-title":"Regulatory RNAs in heart failure","volume":"141","author":"Gomes","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0605","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCRESAHA.118.312751","article-title":"miR-146a suppresses SUMO1 expression and induces cardiac dysfunction in maladaptive hypertrophy","volume":"123","author":"Oh","year":"2018","journal-title":"Circ Res"},{"issue":"54","key":"10.1016\/bs.pmbts.2023.01.002_bb0610","doi-asserted-by":"crossref","first-page":"92079","DOI":"10.18632\/oncotarget.20759","article-title":"Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0615","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.118.12261","article-title":"Circulating long noncoding RNA LIPCAR predicts heart failure outcomes in patients without chronic kidney disease","volume":"73","author":"Santer","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.560537","article-title":"Circulating circular RNAs: novel biomarkers for heart failure","volume":"11","author":"Sun","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0625","article-title":"Emerging epigenetic therapies of cardiac fibrosis and remodeling in heart failure: from basic mechanisms to early clinical development","author":"McKinsey","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0630","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/s41392-022-01055-2","article-title":"Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials","volume":"7","author":"Shi","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0635","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049006","article-title":"Randomized, placebo-controlled trial of mipomersen in patients with severe hypercholesterolemia receiving maximally tolerated lipid-lowering therapy","volume":"7","author":"McGowan","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0640","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41591-021-01634-w","article-title":"Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)","volume":"28","author":"Koren","year":"2022","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0645","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jacc.2021.12.032","article-title":"Effect of Pelacarsen on lipoprotein(a) cholesterol and corrected low-density lipoprotein cholesterol","volume":"79","author":"Yeang","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"10057","key":"10.1016\/bs.pmbts.2023.01.002_bb0650","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0655","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.atherosclerosis.2022.03.029","article-title":"Pre-clinical assessment of SLN360, a novel siRNA targeting LPA, developed to address elevated lipoprotein (a) in cardiovascular disease","volume":"349","author":"Rider","year":"2022","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0660","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11040982","article-title":"Volanesorsen: a new era in the treatment of severe hypertriglyceridemia","volume":"11","author":"Kolovou","year":"2022","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0665","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S2213-8587(21)00046-2","article-title":"Efficacy and safety of volanesorsen in patients with multifactorial chylomicronaemia (COMPASS): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","volume":"9","author":"Gouni-Berthold","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"16","key":"10.1016\/bs.pmbts.2023.01.002_bb0670","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab804","article-title":"Alirocumab after acute coronary syndrome in patients with a history of heart failure","volume":"43","author":"White","year":"2022","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/bs.pmbts.2023.01.002_bb0675","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/bs.pmbts.2023.01.002_bb0680","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"Two phase 3 trials of Inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0685","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1001\/jamacardio.2019.3502","article-title":"Effect of 1 or 2 doses of Inclisiran on low-density lipoprotein cholesterol levels: one-year follow-up of the ORION-1 randomized clinical trial","volume":"4","author":"Ray","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0690","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1161\/ATVBAHA.108.178319","article-title":"Statins control oxidized LDL-mediated histone modifications and gene expression in cultured human endothelial cells","volume":"29","author":"Dje N'Guessan","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0695","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2022.13044","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US preventive services task force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0700","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbrc.2010.01.080","article-title":"SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol","volume":"393","author":"Arunachalam","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"10.1016\/bs.pmbts.2023.01.002_bb0705","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/ATVBAHA.109.187146","article-title":"Resveratrol improves endothelial function: role of TNF{alpha} and vascular oxidative stress","volume":"29","author":"Zhang","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0710","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1868-7083-6-14","article-title":"Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men","volume":"6","author":"Guay","year":"2014","journal-title":"Clin Epigenetics"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0715","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11033-014-3737-x","article-title":"Resveratrol affects histone 3 lysine 27 methylation of vessels and blood biomarkers in DOCA salt-induced hypertension","volume":"42","author":"Han","year":"2015","journal-title":"Mol Biol Rep"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0720","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3892\/etm.2016.3958","article-title":"The effect of resveratrol on hypertension: a clinical trial","volume":"13","author":"Theodotou","year":"2017","journal-title":"Exp Ther Med"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0725","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.111.01009","article-title":"Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism","volume":"62","author":"Carrizzo","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0730","doi-asserted-by":"crossref","first-page":"39469","DOI":"10.1038\/srep39469","article-title":"Ascorbic acid protects against hypertension through downregulation of ACE1 gene expression mediated by histone deacetylation in prenatal inflammation-induced offspring","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"issue":"9195","key":"10.1016\/bs.pmbts.2023.01.002_bb0735","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1016\/S0140-6736(99)04410-4","article-title":"Treatment of hypertension with ascorbic acid","volume":"354","author":"Duffy","year":"1999","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0740","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/eurheartj\/ehaa791","article-title":"CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure","volume":"42","author":"Batkai","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0745","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/CIRCRESAHA.119.315856","article-title":"Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease","volume":"126","author":"Huang","year":"2020","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0750","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-020-14349-2","article-title":"Preclinical development of a miR-132 inhibitor for heart failure treatment","volume":"11","author":"Foinquinos","year":"2020","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/bs.pmbts.2023.01.002_bb0755","doi-asserted-by":"crossref","first-page":"6969","DOI":"10.1002\/jcp.29592","article-title":"Resveratrol suppresses interleukin-6 expression through activation of sirtuin 1 in hypertrophied H9c2 cardiomyoblasts","volume":"235","author":"Akhondzadeh","year":"2020","journal-title":"J Cell Physiol"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0760","article-title":"Resveratrol improves heart function by moderating inflammatory processes in patients with systolic heart failure","volume":"9","author":"Gal","year":"2020","journal-title":"Antioxidants (Basel)"},{"issue":"11","key":"10.1016\/bs.pmbts.2023.01.002_bb0765","doi-asserted-by":"crossref","first-page":"H1558","DOI":"10.1152\/ajpheart.00865.2013","article-title":"Chronic inhibition of phosphodiesterase 5 with tadalafil attenuates mitochondrial dysfunction in type 2 diabetic hearts: potential role of NO\/SIRT1\/PGC-1\u03b1 signaling","volume":"306","author":"Koka","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"16","key":"10.1016\/bs.pmbts.2023.01.002_bb0770","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.14974","article-title":"Effects of phosphodiesterase V inhibition alone and in combination with BNP on cardiovascular and renal response to volume load in human preclinical diastolic dysfunction","volume":"9","author":"Wan","year":"2021","journal-title":"Physiol Rep"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0775","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1159\/000489383","article-title":"Serum Exosomal MiR-92b-5p as a potential biomarker for acute heart failure caused by dilated cardiomyopathy","volume":"46","author":"Wu","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0780","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1089\/nat.2020.0871","article-title":"Efficiency and target derepression of anti-miR-92a: results of a first in human study","volume":"30","author":"Abplanalp","year":"2020","journal-title":"Nucleic Acid Ther"},{"issue":"5","key":"10.1016\/bs.pmbts.2023.01.002_bb0785","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4161\/epi.19633","article-title":"ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia","volume":"7","author":"Guay","year":"2012","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/bs.pmbts.2023.01.002_bb0790","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1474-9726.2012.00835.x","article-title":"Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs","volume":"11","author":"Talens","year":"2012","journal-title":"Aging Cell"},{"issue":"12","key":"10.1016\/bs.pmbts.2023.01.002_bb0795","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.4161\/epi.26554","article-title":"Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status","volume":"8","author":"Houde","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0800","doi-asserted-by":"crossref","first-page":"30053","DOI":"10.1038\/srep30053","article-title":"DNMT1-PPAR\u03b3 pathway in macrophages regulates chronic inflammation and atherosclerosis development in mice","volume":"6","author":"Yu","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0805","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/bs.pmbts.2023.01.002_bb0810","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/cvr\/cvt264","article-title":"Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats","volume":"101","author":"Xiao","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111128","article-title":"Phosphodiesterase 5 (PDE5): structure-function regulation and therapeutic applications of inhibitors","volume":"134","author":"Ahmed","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0820","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41569-019-0235-9","article-title":"Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease","volume":"17","author":"Li","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0825","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4068\/cmj.2016.52.1.1","article-title":"HDAC and HDAC inhibitor: from cancer to cardiovascular diseases","volume":"52","author":"Yoon","year":"2016","journal-title":"Chonnam Med J"},{"issue":"22","key":"10.1016\/bs.pmbts.2023.01.002_bb0830","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","article-title":"Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy","volume":"113","author":"Kong","year":"2006","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0835","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086977","article-title":"Sirtuin 1 (SIRT1) activation mediates sildenafil induced delayed cardioprotection against ischemia-reperfusion injury in mice","volume":"9","author":"Shalwala","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210654","article-title":"Activation of AMPK\/SIRT1 axis is required for adiponectin-mediated preconditioning on myocardial ischemia-reperfusion (I\/R) injury in rats","volume":"14","author":"Potenza","year":"2019","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0845","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21093246","article-title":"Roles of histone acetylation modifiers and other epigenetic regulators in vascular calcification","volume":"21","author":"Kwon","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0850","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fgene.2019.00478","article-title":"The potential for microRNA therapeutics and clinical research","volume":"10","author":"Hanna","year":"2019","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0855","doi-asserted-by":"crossref","DOI":"10.3390\/biom9060226","article-title":"Promising directions in atherosclerosis treatment based on epigenetic regulation using microRNAs and long noncoding RNAs","volume":"9","author":"Skuratovskaia","year":"2019","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0860","doi-asserted-by":"crossref","first-page":"48","DOI":"10.59566\/IJBS.2017.13048","article-title":"Molecular mechanisms and biological functions of siRNA","volume":"13","author":"Dana","year":"2017","journal-title":"Int J Biomed Sci"},{"issue":"15","key":"10.1016\/bs.pmbts.2023.01.002_bb0865","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/bs.pmbts.2023.01.002_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107389","article-title":"BMSCs-derived exosomal microRNA-150-5p attenuates myocardial infarction in mice","volume":"93","author":"Wu","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"10.1016\/bs.pmbts.2023.01.002_bb0875","doi-asserted-by":"crossref","first-page":"5884","DOI":"10.1111\/jcmm.14535","article-title":"MicroRNA-125b in vascular diseases: an updated systematic review of pathogenetic implications and clinical applications","volume":"23","author":"Chao","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/bs.pmbts.2023.01.002_bb0880","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/ejhf.961","article-title":"Circulating microRNA-132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure","volume":"20","author":"Masson","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0885","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.gene.2015.12.032","article-title":"LncRNA MIAT: myocardial infarction associated and more","volume":"578","author":"Liao","year":"2016","journal-title":"Gene"},{"issue":"6","key":"10.1016\/bs.pmbts.2023.01.002_bb0890","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/FJC.0000000000001123","article-title":"CircRNA MFACR is upregulated in myocardial infarction and downregulates miR-125b to promote cardiomyocyte apoptosis induced by hypoxia","volume":"78","author":"Wang","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"10.1016\/bs.pmbts.2023.01.002_bb0895","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/eurheartj\/ehaa898","article-title":"Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human phase 1b randomized, double-blind, placebo-controlled study","volume":"42","author":"T\u00e4ubel","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Progress in Molecular Biology and Translational Science","Epigenetics in Health and Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323000029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877117323000029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T07:17:38Z","timestamp":1753427858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877117323000029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9780443186691"],"references-count":178,"URL":"https:\/\/doi.org\/10.1016\/bs.pmbts.2023.01.002","relation":{},"ISSN":["1877-1173"],"issn-type":[{"value":"1877-1173","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}